Bio-Thera Secures FDA Approval For Sandoz-Partnered Bevacizumab Biosimilar
Avzivi Is The Second Bio-Thera Biosimilar – And The Second Chinese Biosimilar – To Secure FDA Approval
Bio-Thera has received US Food and Drug Administration approval for its bevacizumab biosimilar, marking the second biosimilar drug researched, developed and manufactured by a Chinese pharmaceutical company to receive US approval.
